Abstracts

SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that five abstracts highlighting new data from the Company’s broad hepatitis portfolio addressing both hepatitis B virus (HBV) and…

Media ReleaseCOPENHAGEN, Denmark; May 25, 2023 Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphomaPoster presentations will highlight epcoritamab in lymphoma…

Media Release New data published from Part C of TACTI-002 Phase II Trial evaluating eftilagimod alpha plus pembrolizumab in metastatic 2nd line head and neck squamous cell carcinomaDeep, durable responses seen across all PD-L1 subgroups…

LYON, France and CAMBRIDGE, Mass., May 05, 2023 (GLOBE…

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome…

SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) --…

Abstracts demonstrating XNA technology’s improvements to assay…

<!-- Name:DistributionId Value:8789036 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8788460 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

<!-- Name:DistributionId Value:8786631 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…